Creating precision therapies from the immune response
Atreca is a biotechnology company that is using our proprietary human antibody discovery platform to develop a pipeline of novel cancer antibodies that can enhance and direct the therapeutic effects... Learn more >
A novel class of immuno-oncology therapeutics that direct and enhance checkpoint inhibition
Our proprietary immune profiling technology provides unparalleled insight
Who is Atreca?
A dedicated team of molecular biologists, immunologists, drug developers and computational biologists